HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

'''A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated in 2024; we're aligning the related CCGA content to the new structure.'''

<br />

{| class="wikitable sortable" style="margin:auto"

|-

!Disease (5th Edition)!!Page Type!!<span style="color:#0070C0">Author (5th Edition) (Note: please indicate trainees in parentheses)!!Date Assigned to Author (5th Edition)

|

|-

|Chronic Eosinophilic Leukemia, Not Otherwise Specified

|Chelsea D. Kramish; Daynna J.Wolff

|

|Check reference format

|-

|

|

|Previously within myeloid section under JH/MS editors

|-

|[[HAEM5:Langerhans cell histiocytosis|Langerhans cell histiocytosis]]

|[[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]

|Disease

|

|

|

|

|

|SK

|

|

|

|SK

|Disease

|Holli Drendel, PhD

|

|

|SK

|Karin Miller, MD

|10/9/2025

|

|

|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]]

|Disease

|10/1/2025

|11/17/2025

|Pending

|

|B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like

|10/10/2025

|11/24/2025

|Pending

|

|NEW (No Prior)

|Lei Zhang, PhD

|10/10/2025

|Pending

|

|-

|[[HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS|B-lymphoblastic leukaemia/lymphoma, NOS]]

|

|

|

|

|

|

|

|

|-

!Disease (5th Edition)

!Prior Notes (4th Edition)

|-

====CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)====

|NEW (No Prior)

|NEW (No Prior)

Karin Miller, MD

|3/25/2024

|NEW (No Prior)

|NEW (No Prior)

|

|

|

|SK

|[[HAEM5:T-prolymphocytic leukaemia|T-prolymphocytic leukaemia]]

|Disease

|SK

|

|NEW (No Prior)

|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Nicolas LaScala (trainee);

Michelle Don, MD, MS

|Pending

| ||SK|| ||

|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Hailee St. Louis (trainee);  

Michelle Don, MD, MS

|Chronic Lymphoproliferative Disorder of NK Cells

|Michelle Don, MD

|[[HAEM5:Sezary syndrome|Sezary syndrome]]||Disease||Daynna J. Wolff, PhD

|3/22/2024

|Sézary Syndrome

|Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina

|

|-

|Pending

| ||SK|| ||

!Prior Notes (4th Edition)

|-

| ||SK|| ||

|NEW (No Prior)

Andrew Siref, MD

|NEW (No Prior)

|NEW (No Prior)

|[[HAEM5:Mycosis fungoides|Mycosis fungoides]]||Disease||Daynna J. Wolff, PhD

|3/22/2024

|Mycosis Fungoides

|Jane Scribner, MD and Daynna J. Wolff, PhD

Shashirekha Shetty, PhD

|7/1/2024

| ||SK|| ||

|NEW (No Prior)

|[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]||Disease||Rabail Aslam, MD (fellow);

Shashirekha Shetty, PhD

| ||SK|| ||

|Primary Cutaneous Anaplastic Large Cell Lymphoma

|

|-

|NEW (No Prior)

|NEW (No Prior)

Sumire Kitahara, MD

|6/30/2024

| ||SK|| ||

|NEW (No Prior)

Andrew Siref, MD

|NEW (No Prior)

|NEW (No Prior)

|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);  

Andrew Siref, MD

| ||Pending|| ||SK|| ||

|Enteropathy-Associated T-cell Lymphoma

|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);  

Andrew Siref, MD

| ||Pending|| ||SK|| ||

|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma

| || || || ||SK|| ||

|Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)

|Complete

|9/26/2022

|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Forough Sargolzaeiaval (trainee);  

Michelle Don, MD, MS

|Hepatosplenic T-cell Lymphoma

|Michelle Don, MD, MS

Sumire Kitahara, MD

| ||SK|| ||

|Anaplastic Large Cell Lymphoma, ALK-Positive

|[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma]]||Disease||Miguel Gonzalez Mancera, MD (trainee);

Sumire Kitahara, MD

| ||SK|| ||

|Anaplastic Large Cell Lymphoma, ALK-Negative

|-

|[[HAEM5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||Lynne Abruzzo, MD, PhD

|Breast Implant-Associated Anaplastic Large Cell Lymphoma

|Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD  Cedars-Sinai Medical Center

|-

|[[HAEM5:Nodal TFH cell lymphoma, angioimmunoblastic-type|Nodal TFH cell lymphoma, angioimmunoblastic-type]]||Disease||Rachel Burnside, PhD||7/28/2023

|Angioimmunoblastic T-cell Lymphoma

|Sara Akhavanfard, M.D., Ph.D. and Ruthann Pfau, Ph.D., FACMG

|-

|[[HAEM5:Nodal TFH cell lymphoma, follicular-type|Nodal TFH cell lymphoma, follicular-type]]||Disease||Rachel Burnside, PhD||7/28/2023

|NEW (No Prior)

|NEW (No Prior)

|-

|[[HAEM5:Peripheral T-cell lymphoma, NOS|Peripheral T-cell lymphoma, NOS]]||Disease||Bo Hong, MD

|NEW (No Prior)

|NEW (No Prior)

|[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee);

Andrew Siref, MD

|NEW (No Prior)

|NEW (No Prior)

|NEW (No Prior)

|-

| ||SK|| ||

|NEW (No Prior)

|[[HAEM5:Systemic chronic active EBV disease|Systemic chronic active EBV disease]]||Disease||Karin Miller, MD

|3/25/2024

|NEW (No Prior)

|NEW (No Prior)

|[[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood|Systemic EBV-positive T-cell lymphoma of childhood]]||Disease||Karin Miller, MD

|3/25/2024

|Systemic EBV-Positive T-cell Lymphoma of Childhood

|Lisa A. Lansdon, PhD and Linda D. Cooley, MD, MBA

|NEW (No Prior)

|NEW (No Prior)

|-

|[[HAEM5:Littoral cell angioma|Littoral cell angioma]]

|NEW (No Prior)

|NEW (No Prior)

|-

|